SILVER SPRING, MD
4 risk indicators measuring financial stability and operational resilience
Sign in with your work email to view Tuckman-Chang indicators
Sign In — Free (10 views/day)FOUNDATION FOR RARE DISEASE RESEARCH INC, founded in 2022, is a small nonprofit in the Medical Research sector that reported $339K in total revenue in fiscal year 2025. Revenue fell 49% from the prior year — a significant decline worth monitoring. The organization ran a surplus of $235K, a strong 69% operating margin.
Discover, pursue and support the development of clinical diagnostics tools that can lead to cures for rare and orphan diseases by contributing to the advancement in research and development.
The organization conducts research on rare diseases, including hereditary angioedema. During the year, the organization continued development of a method to measure the biomarker Bradykinin for use...
The organization conducts research on rare diseases, including hereditary angioedema. During the year, the organization continued development of a method to measure the biomarker Bradykinin for use in clinical diagnosis and therapy monitoring. Research activities were carried out by contracted scientific service providers, and results were presented at professional meetings to support patient care and clinician education.
Financial Health Score (300–850) · Liquidity · Solvency · Sustainability · Efficiency
Sign in to view Trantor Score and financial metrics
Liquidity (40%) • Solvency (30%) • Sustainability (20%) • Efficiency (10%)
Sign In — Free (10 views/day)| 2025 | 2024 | Change | |
|---|---|---|---|
| Revenue | $339,269 | $668,532 | -0.5% |
| Expenses | $104,396 | $1,533,144 | -0.9% |
| Net Income | $234,873 | $-864,612 | -1.3% |
Comprehensive financial analysis: Altman Z-Score, liquidity, solvency, sustainability, efficiency, and growth metrics
Financial Distress Indicator
Liquidity & Cash Position
Sign in to view all financial metrics
Altman Z-Score • Liquidity Ratios • Solvency Analysis • Growth Indicators • Efficiency Metrics
Sign In| Name | Title | Hours/Week | Role | Reportable Comp | Other Comp | Total |
|---|---|---|---|---|---|---|
| HUAMIN LI | President | 1.00 |
Officer
Director
|
$0 | $0 | $0 |
| JOSEPH CHIAO | Secretary | 1.00 |
Officer
Director
|
$0 | $0 | $0 |
| JUAN YU | Treasurer | 1.00 |
Officer
Director
|
$0 | $0 | $0 |
| LILI WAN | Vice President | 1.00 |
Officer
Director
|
$0 | $0 | $0 |
| SHAOBIN HOU | Vice President | 1.00 |
Officer
Director
|
$0 | $0 | $0 |
| Year | Revenue | Expenses | Assets | Net Income |
|---|---|---|---|---|
| 2025 | $339,269 | $104,396 | $2,367,680 | $234,873 |
| 2024 | No data | No data | No data | No data |
| 2023 | $1,319,799 | $2,380 | $2,997,419 | $1,317,419 |
| 2022 | $1,680,000 | No data | $1,680,000 | No data |
Compare FOUNDATION FOR RARE DISEASE RESEARCH INC with other nonprofits in Maryland and across the country.